Cargando…
Foresight in clinical proteomics: current status, ethical considerations, and future perspectives
With the advent of robust and high-throughput mass spectrometric technologies and bioinformatics tools to analyze large data sets, proteomics has penetrated broadly into basic and translational life sciences research. More than 95% of FDA-approved drugs currently target proteins, and most diagnostic...
Autores principales: | Mundt, Filip, Albrechtsen, Nicolai J. Wewer, Mann, Sebastian Porsdam, Treit, Peter, Ghodgaonkar-Steger, Medini, O’Flaherty, Martina, Raijmakers, Reinout, Vizcaíno, Juan Antonio, Heck, Albert J.R., Mann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446044/ https://www.ncbi.nlm.nih.gov/pubmed/37645494 http://dx.doi.org/10.12688/openreseurope.15810.2 |
Ejemplares similares
-
Ethical Principles, Constraints, and Opportunities in Clinical Proteomics
por: Mann, Sebastian Porsdam, et al.
Publicado: (2021) -
Foresight for ethical AI
por: Dorton, Stephen L., et al.
Publicado: (2023) -
Plasma Proteomes Can Be Reidentifiable and Potentially Contain Personally Sensitive and Incidental Findings
por: Geyer, Philipp E., et al.
Publicado: (2021) -
A framework for the ethical assessment of chimeric animal research involving human neural tissue
por: Porsdam Mann, Sebastian, et al.
Publicado: (2019) -
Maximising impactful, locally relevant global mental health research conducted in low and middle income country settings: ethical considerations
por: Calia, Clara, et al.
Publicado: (2023)